Nestlé Health Science Acquires Majority Stake in Orgain

Butterfly Equity Acquires Majority Stake in Orgain

November 8, 2019

Food & Beverage

Butterfly Equity has signed a definitive agreement to acquire a majority stake in Orgain, a Los Angeles-area private equity firm said in a press release. Ontario Teachers' Pension Plan will join as a minority investor, and Orgain founder Dr. Andrew Abraham will retain a significant minority stake and remain CEO; the partnership is intended to scale the brand, accelerate product innovation and expand global distribution.

Nestlé Health Science Acquires Majority Stake in Vital Proteins

June 10, 2020

Food & Beverage

Nestlé Health Science (NHSc), a subsidiary of Nestlé, agreed to acquire a majority stake in Vital Proteins, the US market leader in collagen-based supplements, beverages and food products. Vital Proteins will continue to operate as a standalone business under CEO Kurt Seidensticker, with the deal intended to accelerate global expansion and product innovation.

Nestlé Health Science Acquires Nuun from TSG Consumer Partners

May 10, 2021

Food & Beverage

Nestlé Health Science has agreed to acquire Nuun, a Seattle-based hydration supplement brand, from private equity firm TSG Consumer Partners. Financial terms were not disclosed and the transaction was expected to close in the second half of 2021.

Summa Equity Acquires Majority Stake in Nutris

September 3, 2024

Food & Beverage

Impact investor Summa Equity has acquired a majority stake in Nutris, a Croatian plant-based protein ingredients manufacturer founded in 2019. The investment will support scaling Nutris’s manufacturing capacity and R&D to expand production of fava-bean protein isolates and other plant-based ingredients for food, sports nutrition and dairy/meat alternative markets.

Nestlé Acquires The Bountiful Company's Core Vitamin Brands for $5.75B

August 9, 2021

Food & Beverage

Nestlé (via Nestlé Health Science) agreed to acquire the core vitamin and supplement brands of The Bountiful Company from KKR and Carlyle for $5.75 billion, integrating brands such as Nature's Bounty, Solgar, Puritan's Pride and Osteo Bi‑Flex into its NHSc portfolio. The deal (expected/closed in H2 2021) brings roughly 4,000–4,500 employees into Nestlé Health Science and establishes Nestlé as a global leader in vitamins, minerals and nutritional supplements across mass retail, specialty retail and e‑commerce.

Nestlé Health Science / Société des Produits Nestlé S.A. to acquire Aimmune Therapeutics

August 31, 2020

Pharmaceuticals

Nestlé Health Science (NHSc), via a Nestlé S.A. acquisition subsidiary (Société des Produits Nestlé S.A.), agreed to acquire Aimmune Therapeutics for USD34.50 per share in cash, valuing the company at approximately USD2.6 billion. NHSc already owned ~25.6% of Aimmune; the tender offer is expected to close in Q4 2020 and will expand Nestlé's portfolio with Aimmune's FDA-approved peanut allergy therapy Palforzia.